Answers are grounded in this paper and cite their sources.
BPT results in a significant decrease in 5-year OS in patients who are treated for HL. Age > or = 40 years seems to add substantially to the risk. In patients who do not die from acute pulmonary toxicity, both OS and PFS seem equal, despite the omission of bleomycin.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: